202 related articles for article (PubMed ID: 25751089)
1. Diazirine photocrosslinking recruits activated FTO demethylase complexes for specific N(6)-methyladenosine recognition.
Jeong HS; Hayashi G; Okamoto A
ACS Chem Biol; 2015 Jun; 10(6):1450-5. PubMed ID: 25751089
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into FTO's catalytic mechanism for the demethylation of multiple RNA substrates.
Zhang X; Wei LH; Wang Y; Xiao Y; Liu J; Zhang W; Yan N; Amu G; Tang X; Zhang L; Jia G
Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2919-2924. PubMed ID: 30718435
[TBL] [Abstract][Full Text] [Related]
3. m
Huff S; Tiwari SK; Gonzalez GM; Wang Y; Rana TM
ACS Chem Biol; 2021 Feb; 16(2):324-333. PubMed ID: 33412003
[No Abstract] [Full Text] [Related]
4. SFPQ Is an FTO-Binding Protein that Facilitates the Demethylation Substrate Preference.
Song H; Wang Y; Wang R; Zhang X; Liu Y; Jia G; Chen PR
Cell Chem Biol; 2020 Mar; 27(3):283-291.e6. PubMed ID: 31981477
[TBL] [Abstract][Full Text] [Related]
5. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
6. Decreased N(6)-methyladenosine in peripheral blood RNA from diabetic patients is associated with FTO expression rather than ALKBH5.
Shen F; Huang W; Huang JT; Xiong J; Yang Y; Wu K; Jia GF; Chen J; Feng YQ; Yuan BF; Liu SM
J Clin Endocrinol Metab; 2015 Jan; 100(1):E148-54. PubMed ID: 25303482
[TBL] [Abstract][Full Text] [Related]
7. Novel positioning from obesity to cancer: FTO, an m
Chen J; Du B
J Cancer Res Clin Oncol; 2019 Jan; 145(1):19-29. PubMed ID: 30465076
[TBL] [Abstract][Full Text] [Related]
8. Identification of Flavin Mononucleotide as a Cell-Active Artificial N
Xie LJ; Yang XT; Wang RL; Cheng HP; Li ZY; Liu L; Mao L; Wang M; Cheng L
Angew Chem Int Ed Engl; 2019 Apr; 58(15):5028-5032. PubMed ID: 30756480
[TBL] [Abstract][Full Text] [Related]
9. Identification of Specific
Zhang Y; Li QN; Zhou K; Xu Q; Zhang CY
Anal Chem; 2020 Oct; 92(20):13936-13944. PubMed ID: 32972135
[TBL] [Abstract][Full Text] [Related]
10. FTO, m
Mauer J; Jaffrey SR
FEBS Lett; 2018 Jun; 592(12):2012-2022. PubMed ID: 29754392
[TBL] [Abstract][Full Text] [Related]
11. FTO: An Emerging Molecular Player in Neuropsychiatric Diseases.
Annapoorna PK; Iyer H; Parnaik T; Narasimhan H; Bhattacharya A; Kumar A
Neuroscience; 2019 Oct; 418():15-24. PubMed ID: 31442565
[TBL] [Abstract][Full Text] [Related]
12. The Molecular Basis of Human ALKBH3 Mediated RNA N
Zhang L; Duan HC; Paduch M; Hu J; Zhang C; Mu Y; Lin H; He C; Kossiakoff AA; Jia G; Zhang L
Angew Chem Int Ed Engl; 2024 Feb; 63(7):e202313900. PubMed ID: 38158383
[TBL] [Abstract][Full Text] [Related]
13. RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells.
Tsuruta N; Tsuchihashi K; Ohmura H; Yamaguchi K; Ito M; Ariyama H; Kusaba H; Akashi K; Baba E
Biochem Biophys Res Commun; 2020 Sep; 530(1):235-239. PubMed ID: 32828292
[TBL] [Abstract][Full Text] [Related]
14. Reversible RNA adenosine methylation in biological regulation.
Jia G; Fu Y; He C
Trends Genet; 2013 Feb; 29(2):108-15. PubMed ID: 23218460
[TBL] [Abstract][Full Text] [Related]
15. Preparation of Human Nuclear RNA m⁶A Methyltransferases and Demethylases and Biochemical Characterization of Their Catalytic Activity.
Liu J; Yue Y; He C
Methods Enzymol; 2015; 560():117-30. PubMed ID: 26253968
[TBL] [Abstract][Full Text] [Related]
16. m
Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y
Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060
[TBL] [Abstract][Full Text] [Related]
17. Differential m
Wei J; Liu F; Lu Z; Fei Q; Ai Y; He PC; Shi H; Cui X; Su R; Klungland A; Jia G; Chen J; He C
Mol Cell; 2018 Sep; 71(6):973-985.e5. PubMed ID: 30197295
[TBL] [Abstract][Full Text] [Related]
18. Sequence-specific m
Rau K; Rösner L; Rentmeister A
RNA; 2019 Oct; 25(10):1311-1323. PubMed ID: 31263003
[No Abstract] [Full Text] [Related]
19. FTO-mediated formation of N6-hydroxymethyladenosine and N6-formyladenosine in mammalian RNA.
Fu Y; Jia G; Pang X; Wang RN; Wang X; Li CJ; Smemo S; Dai Q; Bailey KA; Nobrega MA; Han KL; Cui Q; He C
Nat Commun; 2013; 4():1798. PubMed ID: 23653210
[TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO.
Jia G; Fu Y; Zhao X; Dai Q; Zheng G; Yang Y; Yi C; Lindahl T; Pan T; Yang YG; He C
Nat Chem Biol; 2011 Oct; 7(12):885-7. PubMed ID: 22002720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
